openPR Logo
Press release

Lipid Analysis Devices Market - By Application, Type, and End Users - Global Industry Insights, Trends, Outlook, 2018-2026

07-05-2018 09:23 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Lipid Analysis Devices Market - By Application, Type, and End

The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider application as compared to clinical analyzers due to its low cost, accuracy, ease of use, and rapidity of producing results. The lipid analysis devices market is propelled by rising incidence of abnormal levels of lipids and technological advancements while factors such as high pricing of clinical based analyzers and stringent as well as time consuming regulatory policies are expected to hamper growth of lipid analysis devices market.

To get holistic SAMPLE of the report including table of contents: https://www.coherentmarketinsights.com/ongoing-insight/toc/1488

Lipid analysis devices market Taxonomy:

By Application

Hyperlipidemia
Hypertriglyceridemia
Familial Hypercholesterolemia
Hyperlipoproteinemia
Tangier Disease

By Type

Clinical Analyzer
Point-of-care devices

By End Users

Hospitals
Diagnostic clinics
Homecare settings

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1488

Lipid Analysis Devices Market Drivers

The lipid analysis test results were subjected to many drawbacks during patient handling such as inaccuracy in the results due to improper fasting and medications, human error, and various other factors, which gives false negative or false positive results. Therefore, to overcome such drawbacks, lipid analysis market demands for new technology-based devices, which will propel growth of lipid analysis devices market. According to the American Diabetes Association, heart attack or stroke affect people with diabetes more than twice as often as people without diabetes. Therefore, Polymer Technology Systems Diagnostics, in 2013, introduced CardioChek Plus analyzer at the annual American Association for Clinical Chemistry (AACC), which can be used for analyzing both lipid and glucose levels simultaneously. Furthermore, the CardioChek Plus analyzer system is Wi-Fi enabled and can transmit test results of patients to data collection applications. In 2013, Acon Laboratories, Inc., launched the Mission Cholesterol Monitoring system, which can perform 3 tests; total cholesterol (CHOL), high density lipoprotein (HDL), and triglycerides (TRIG).

Lipid disorder is a medical condition where the patient has elevated levels of plasma cholesterol or triglycerides (TG), or both, or a low high-density lipoprotein (HDL) level, which leads to long-term problems such as atherosclerosis, elevated blood pressure, obesity, and diabetes mellitus. Dyslipidemia is a metabolic syndrome where blood lipid levels are elevated leading to increased risk of coronary heart disease (CHD). For instance, according to Registrar General of India, coronary heart disease led to around 17% of the total deaths in 2001-2003, which increased to around 23% in 2010-2013. According to the Centers for Disease Control and Prevention (CDC), in 2015, high blood cholesterol was the leading cause of death in the U.S. and people with high cholesterol had about twice the risk of heart disease, as compared to people with lower cholesterol level. Such high prevalence of high cholesterol and coronary heart disease globally is expected to propel growth of the lipid analysis device market. Furthermore, increasing awareness of lipid analysis devices especially kits among the population is expected to drive growth of the market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Blog: https://globalresearchtrends.blogspot.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lipid Analysis Devices Market - By Application, Type, and End Users - Global Industry Insights, Trends, Outlook, 2018-2026 here

News-ID: 1110979 • Views:

More Releases from Coherent Market Insights

Pet Milk Replacement Products Market Top Vendors, Regional Growth and Forecast by 2024-2031 | Pet-Ag, Inc., The Hartz Mountain Corporation
Pet Milk Replacement Products Market Top Vendors, Regional Growth and Forecast b …
Pet milk replacement products are healthy alternatives for puppies & kittens, who are deprived of milk from their mother due to high litter number, or illness of the mother. Dog and cat cafes and non-profit organizations across the globe are taking initiatives to give shelter to such puppies & kittens. The latest report published by Coherent Market Insights highlights the growth prospects of the Pet Milk Replacement Products Market from 2024
Future Growth : Contract Research Organization Services Market Development Factors, Current and Business Outlook, Critical Insight l 2031 | Charles River, Wuxi PharmaTech, Medpace Holdings
Future Growth : Contract Research Organization Services Market Development Facto …
★ Synopsis Of The Report A new study titled Contract Research Organization Services Market 2024, published by The Coherent Market Insights, provides information on regional and global markets that is anticipated to increase in value between 2024 and 2031. The extensive research on the global Contract Research Organization Services Market offers important insights into the market's shifting dynamics, value chain analysis, well-known investment hotspots, competitive scenarios, regional landscape, and major segments.
Gallbladder Cancer Market Expected to Expand at a Steady 2024-2031 | Bristol-Myers Squibb, Roche, Pfizer, Novartis
Gallbladder Cancer Market Expected to Expand at a Steady 2024-2031 | Bristol-Mye …
New Research Study Gallbladder Cancer Market 2024 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share and Outlook has been added to Coherent Market insight. The study of the Gallbladder Cancer Market provides an in-depth analysis of the market for the projected time frame (2024-2030). There are other parts in the study that moreover analyze the trends and variables that are significantly influencing the industry. The
Traumatic Brain Injury Therapeutics Market Size: Emerging Rapidly with Global Latest Trends, Growth, Revenue, Demand and Forecast to 2031 | Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Pfizer Inc
Traumatic Brain Injury Therapeutics Market Size: Emerging Rapidly with Global La …
New Research Study Traumatic Brain Injury Therapeutics Market 2024 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and Investment Opportunities), Size, Share and Outlook has been added to Coherent Market insight. The study of the Traumatic Brain Injury Therapeutics Market provides an in-depth analysis of the market for the projected time frame (2024-2030). There are other parts in the study that moreover analyze the trends and variables that are significantly

All 5 Releases


More Releases for Lipid

Business Research of Lipid Disorder Treatment
The global lipid disorders treatment market is estimated to grow at a significant rate, states Transparency Market Research, in its recent report. The analysis on lipid disorders projects the market of lipid disorder treatment is likely to reach around worth of US$40 bn by the end of year 2026. Development of the global market is pushed by advancement in the treatment for lipid digestion disorders. Read Report Overview - https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html Organizations associated
Lipid Nanoparticles, Key Component of COVID-19 mRNA Vaccines
Lipid nanoparticles have been developed as vehicles for small molecule delivery by the nanomedicine and materials communities and are now a key component of COVID-19 mRNA vaccines. Vaccines against COVID-19 have been developed with unprecedented speed. In particular, mRNA vaccines — a technology already in clinical trials for other infectious diseases, such as influenza — have shown impressive efficacy in clinical trials.  mRNA vaccines rely on the delivery of mRNA into the
Lipid Nutrition Market Size & Analysis - Forecasts to 2026
The results evaluated by GME suggested that by 2026, the Global Lipid Nutrition Market will grow with a 9.1 percent CAGR from 2021 to 2026. The growing availability of a vegan source of lipid nutrition along with the increasing occurrence of natural products will boost the outlook for the industry in the forthcoming years. Browse 157 Market Data Tables and 117 Figures spread through 187 Pages and in-depth TOC on "Global
Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider
Lipid Coated Bead Products - Exclusive Tools From Echelon for Protein-Lipid Inte …
MoBiTec's partner company Echelon Biosciences, USA, is excited to introduce a new class of lipid microparticles small enough to be used in phagocytosis experiments! Phosphatidylserine (PS), Phosphatidylcholine (PC), and PC/PS microparticles have phospholipids attached in a unique way allowing headgroups to be exposed and available for the study of biological interactions. Their size, approximately 3 µm, are ideal for phagocytosis and accommodates analysis with standard flow cytometry and microscopy methods. Lipid
Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider